首页> 外文OA文献 >Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: Three areas for future research Which areas to target? Which particle size to deliver? Which device to use?

【2h】

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: Three areas for future research Which areas to target? Which particle size to deliver? Which device to use?

机译：囊性纤维化患者肺部疾病的吸入式药物和吸入装置：未来研究的三个领域针对哪些领域？提供哪种粒度？使用哪个设备？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Rottier, Bart L.; de Boer, Anne H.; Duiverman, Eric J.;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use? [J] . Rottier BL, de Boer AH, Duiverman EJ Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society . 2010,第4期

机译：囊性纤维化患者肺部疾病的吸入式药物和吸入装置：未来研究的三个领域提供哪种粒度？使用哪个设备？
2. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it. [J] . Duff AJ, Latchford GJ Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society . 2010,第6期

机译：患有囊性纤维化患者的肺部疾病的吸入药物和吸入装置：依从性差且需要解决。
3. AZTREONAM LYSINE INHALATION SOLUTION STABILISES LUNG FUNCTION DECLINE IN PATIENTS WITH CYSTIC FIBROSIS AND MODERATE TO SEVERE LUNG DISEASE [J] . Chadwick H. K., White H., Shaw N., Pediatric Pulmonology . 2018,第Suppla2期

机译：Aztreonam Lysine吸入溶液稳定患患者囊性纤维化和中度至严重肺病患者的肺功能下降
4. PARTICLE SIZE DISTRIBUTION FROM CAPSULES DELIVERED BY THE MICRO-HALER~(TM) AS INHALATION DEVICE [C] . Helena M. Cabral Marques, Peter C. Schmidt Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002

机译：MICRO-HALER〜（TM）作为吸入装置提供的胶囊中的颗粒尺寸分布
5. Biodegradable nanoparticles for use as an inhalable antimicrobial and as a receptor targeted delivery device. [D] . Ditto, Andrew James. 2010

机译：可生物降解的纳米颗粒，用作可吸入的抗菌剂和受体靶向的递送装置。
6. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion Corrigendum [O] . 2021

机译：不同吸入装置慢性阻塞性肺病患者的肺沉积和吸气流速：系统文献综述与专家意见勘误
7. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis:Three areas for future research Which areas to target? Which particle size to deliver? Which device to use? [O] . Rottier, Bart L., de Boer, Anne H., Duiverman, Eric J. 2010

机译：囊性纤维化患者肺部疾病的吸入式药物和吸入装置：三个领域有待进一步研究提供哪种粒度？使用哪个设备？
8. Effects of Inhaled Fine Particles on Lung Growth and Lung Disease. Final Report [R] . Kleinman, M. T. 2010

机译：吸入细颗粒物对肺部生长和肺部疾病的影响。总结报告

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: Three areas for future research Which areas to target? Which particle size to deliver? Which device to use?

著录项

相似文献

相关主题

期刊订阅